Cardinal Health Inc
CAH
Company Profile
- Business description- Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia. 
- Contact- 7000 Cardinal Place 
 DublinOH43017
 USA- T: +1 614 757-5000 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Distribution - Fiscal Year End- 30 June 2026 - Employees- 57,700 
Cardinal Health Inc News & Analysis
stocks
Spotlight on 10 undervalued US equities
Companies with a history of paying - or increasing - dividends tend to be favoured by investors, as competitively well-positioned, steady cash-generating businesses.
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,230.10 | 23.40 | 0.25% | 
| CAC 40 | 8,157.29 | 43.59 | -0.53% | 
| DAX 40 | 24,118.89 | 5.32 | -0.02% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,760.06 | 3.92 | 0.04% | 
| HKSE | 26,282.69 | 63.45 | -0.24% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 52,199.36 | 873.75 | 1.70% | 
| NZX 50 Index | 13,529.28 | 69.99 | 0.52% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,933.20 | 20.00 | 0.22% | 
| SSE Composite Index | 3,986.86 | 0.04 | -0.00% |